Enterprise League logo
SCYNEXIS, Inc. Logo

SCYNEXIS, Inc.

Jersey City, United States (US) · Health and Medical

Do your work at SCYNEXIS, Inc.?

Claim this profile to manage your company.

Verified by Enterprise League

Data quality

Complete · Accuracy

Last verified

May 2026

Overview

SCYNEXIS, Inc is a US-based biotechnology company specializing in the development of innovative therapies for severe, rare diseases.

We are dedicated to improving patient outcomes by targeting the underlying biology of these conditions, particularly focusing on unmet medical needs. Our core approach centers around developing highly differentiated, clinical-stage assets, including direct AMPK activators like SCY-770 and antifungal triterpenoids such as SCY-247.

SCYNEXIS is committed to advancing groundbreaking scientific breakthroughs that offer meaningful benefit to patients facing limited treatment options. Founded in 2000, we operate with a disciplined drug development execution and a focus on delivering impactful results. We are a public company (NASDAQ: SCYX) and are actively pursuing opportunities to transform the lives of individuals affected by rare diseases.

Most teams do this before shortlisting


Contact Details

info@scynexis.com

Jersey City, United States (US), 1 Evertrust Plaza

Founded

2000

Company Type

Public Limited Company

Employees

30-50

Keywords

#drug development

#biotech

#infectious disease

#fungal disease

#rare disease

#adpkd

Companies teams usually look at after SCYNEXIS, Inc.

Comparing a few options usually leads to better decisions






  • Save companies to compare later. Useful when sharing options with your team

This is how your company profile looks to others.